Everence Capital Management Inc Pacira Bio Sciences, Inc. Transaction History

Everence Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	BUY	$30.68 - $40.09 $86,824 - $113,454	2,830 Added 46.32%	8,940 $274,000
Q3 2022 Oct 07, 2022	BUY	$51.24 - $58.89 $106,579 - $122,491	2,080 Added 51.61%	6,110 $325,000
Q1 2022 Apr 11, 2022	BUY	$60.03 - $76.49 $241,920 - $308,254	4,030 New	4,030 $308,000
Q3 2021 Oct 21, 2021	SELL	$54.64 - $61.3 $256,808 - $288,110	-4,700 Closed	0 $0
Q1 2021 Apr 06, 2021	BUY	$59.31 - $78.82 $278,757 - $370,453	4,700 New	4,700 $329,000
Q3 2020 Oct 20, 2020	SELL	$51.97 - $63.0 $358,593 - $434,700	-6,900 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$36.31 - $46.83 $250,539 - $323,127	6,900 New	6,900 $313,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Everence Capital Management Inc with notifications on news.